Page last updated: 2024-10-24

cefuroxime and Acanthamoeba Meningoencephalitis

cefuroxime has been researched along with Acanthamoeba Meningoencephalitis in 1 studies

Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.

Research Excerpts

ExcerptRelevanceReference
"A working diagnosis of severe septicemia with acute meningoencephalitis was then made and the patient was started on IV Cephtriaxone (2 g) twice daily."1.46A case report: primary amoebic meningoencephalitis in a young Zambian adult. ( Chomba, M; Fwoloshi, S; Mucheleng'anga, LA; Mutengo, MM; Ngulube, J, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chomba, M1
Mucheleng'anga, LA1
Fwoloshi, S1
Ngulube, J1
Mutengo, MM1

Other Studies

1 other study available for cefuroxime and Acanthamoeba Meningoencephalitis

ArticleYear
A case report: primary amoebic meningoencephalitis in a young Zambian adult.
    BMC infectious diseases, 2017, 08-01, Volume: 17, Issue:1

    Topics: Amphotericin B; Animals; Anti-Bacterial Agents; Cefuroxime; Central Nervous System Protozoal Infecti

2017